webinar register page

Webinar banner
Roche’s virtual event on two year data of Evrysdi in patients with type 2 or type 3 spinal muscular atrophy presented at the 2021 MDA virtual conference
* Required information

By registering, I agree to the Privacy Statement and Terms of Service.



Paulo Fontoura, M.D. Ph.D
Global Head Neuroscience and Rare Diseases Clinical Development
Simona Skerjanec
Therapeutic Area Head Neuroscience and Rare Diseases, Global Product Strategy